SMYD3 Promotes Immune Evasion in Clear Cell Renal Cell Carcinoma via SREBP1‐Mediated Transactivation of CD47
Advanced Science · 2025
DOI: 10.1002/advs.202404200 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Zhengfang Liu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Thoracic Surgery Department, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan…. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Histone-Lysine N-Methyltransferase, Sterol Regulatory Element Binding Protein 1. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Postdoctoral Science Foundation, National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Cancer cell‐intrinsic features (e.g., genetic aberrations and dysregulation of signaling pathways) play pivotal roles in orchestrating the composition and functional state of the immune landscape, which in turn impact tumor progression and response to immunotherapy. Here, it is discovered that dysregulation of cancer cell‐intrinsic SET and MYND domain‐containing protein 3 (SMYD3) leads to the orchestration of an immunosuppressive microenvironment and the impairment of responses to PD‐1 blockade by reprogramming the infiltration of immune cells in the tumor microenvironment of clear cell renal cell carcinoma (ccRCC). SMYD3 cooperates with Sp1 to transcriptionally promote sterol regulatory element‐binding protein 1 (SREBP1) expression by modifying H3‐K4 di‐/trimethylation and consequently activating the transcription of CD47. CD47, a bridge between innate and adaptive immunity, acts as the downstream effector molecule of the SMYD3 signal to promote the infiltration of T helper 2 (Th2) cells, protecting renal cancer cells from immune attack. In summary, the critical role of the cancer cell‐intrinsic SMYD3‐SREBP1‐CD47 axis is elucidated in regulating the immune microenvironment in ccRCC and provides a potential therapeutic strategy to manipulate the tumor immune milieu in favor of antitumor immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Thoracic Surgery Department, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Science, Jinan, 250117, China.
- Department of Urology, Qilu Hospital of Shandong University, Jinan, 2500112, China.
- Department of Pathology, Qilu Hospital of Shandong University, Jinan, 250012, China.
- Department of Hematology, The Second Hospital of Shandong University, Jinan, 250033, China.
- Department of Urology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Medicine and Health Key Laboratory of Organ Transplantation and Nephrosis, Sh…
- Translational Chinese Medicine Key Laboratory of Sichuan Province, Sichuan Institute for Translational Chinese Medicine, Sichuan Academy of Chinese Medicine Sciences, Chengdu, 610042, China.
ORCID-Profile: Zhengfang Liu
Förderung
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
- Taishan Scholar Foundation of Shandong Province
Zitieren
APA
Liu, Z., Zhao, X., Zang, M., Yuan, H., Qin, X., Li, X., Zhao, S., Tan, R., Yan, K., Liu, L., Fan, Y., Zhang, N., Shi, B., Han, B., & Chen, S. (2025). SMYD3 Promotes Immune Evasion in Clear Cell Renal Cell Carcinoma via SREBP1‐Mediated Transactivation of CD47. Advanced Science. https://doi.org/10.1002/advs.202404200
Vancouver
Liu Z, Zhao X, Zang M, Yuan H, Qin X, Li X, et al. SMYD3 Promotes Immune Evasion in Clear Cell Renal Cell Carcinoma via SREBP1‐Mediated Transactivation of CD47. Advanced Science. 2025. doi:10.1002/advs.202404200
BibTeX
@article{Liu2025,
author = {Liu, Zhengfang and Zhao, Xiumei and Zang, Maolin and Yuan, Huiyang and Qin, Xin and Li, Xiaofeng and Zhao, Shuo and Tan, Ruirong and Yan, Keqiang and Liu, Li and Fan, Yidong and Zhang, Ning and Shi, Benkang and Han, Bo and Chen, Shouzhen},
title = {SMYD3 Promotes Immune Evasion in Clear Cell Renal Cell Carcinoma via SREBP1‐Mediated Transactivation of CD47},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202404200}
}
EUVIMED